Bristol-Myers Squibb Co

LIM : BMY

USA·Healthcare·Drug Manufacturers

$53.06

+0.00 (+0.00%)latest daily quote

Market Cap

$108.06B

Enterprise Value

$144.55B

P/E (TTM)

18.07

P/B

6.87

Net Cash / (Debt)

−$36.47B

52-Week Range

$44 — $54

5-Year Range

$40 — $60

Avg Volume (3M)

539

Bristol-Myers Squibb Co Investor Event to Discuss Results from Phase 3 True North Trial Evaluating Zeposia (ozanimod) in Ulcerative Colitis at UEG Week 2020 Transcript

2020-10-12Analyst/Investor Call

Read the full earnings transcript with Waltermetrics Pro

The complete transcript text is available to Pro members.